Wyeth at outperform by Bear Stearns

Wyeth was rated at outperform with a $55 price target by Bear Stearns analyst John Boris as the diet drug saga continues and the company reaches an agreement in principal. Prevnar is expected to accelerate in the second quarter as vaccination programs are launched in the United Kingdom and The Netherlands. Wyeth has shipped 1 million doses to the United Kingdom. Shares of the Madison, N.J., pharmaceutical company were up $0.24 or 0.50%, at $48.24 on volume of 4,614,600 shares versus the three-month running average of 4,435,310 shares. (NYSE: WYE)

Bear Stearns puts Roche at outperform

Roche was rated at outperform with a CHF280 price target by Bear Stearns analyst Rachna Upadhya. CERA for treating anaemia could be a multi-billion dollar asset but it continues to face uncertainties. According to the analyst, phase 3 data has not yet been presented, its exact molecular structure is unknown, and the patent dispute with Amgen raises doubts over its potential launch in the United States. Shares of the Basel, Switzerland, pharmaceutical company were up CHF0.40, or 0.21%, at CHF195.00 on volume of 2,222,233 shares versus the three-month running average of 2,792,350 shares. (VTX: ROG.VX)

Speedel reinstated at neutral rating by Merrill

Merrill Lynch analyst Erica Whittaker reinstated coverage of Speedel Holdings at a downgraded neutral from buy rating. Shares are now trading close to Merrill's sum-of-parts valuation of CHF185 per share. The stock is not likely to outperform in the next 6 to 9 months due to lack of significant news flow catalysts. Shares of the Basel, Switzerland, biopharmaceutical company were down CHF1.70, or 0.94%, at CHF179.90 on volume of 6,070 shares versus the three-month running average of 10,057 shares. (SWX: SPPN SW)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.